| Multiple Sclerosis |
1 |
1 |
| Injury |
0 |
0.61 |
| Multiple Sclerosis Progression |
0 |
0.41 |
| Neuron |
0 |
0.35 |
| Academia |
0 |
0.2 |
| Behavioral Modification Therapy |
0 |
0.2 |
| Clinical Research |
0 |
0.2 |
| Europe |
0 |
0.2 |
| Interprofessional Continuing Education |
0 |
0.2 |
| Multiple Sclerosis Treatment |
0 |
0.2 |
| Myelin |
0 |
0.2 |
| Nerve |
0 |
0.2 |
| Pollutant |
0 |
0.2 |
| Salary and Compensation |
0 |
0.2 |
| Toxicology |
0 |
0.16 |
| Wound Management |
0 |
0.16 |
| Biologic Therapy |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.05 |
| Revenue and Practice Management |
0 |
0.05 |